Please login to the form below
AZ said to be eyeing Forest takeover bid
Financial Times says pharma companies are in early negotiations
Celgene signs $3.3bn cancer deal with OncoMed
Includes lead candidate demcizumab
EMA: more fee reductions for orphan drugs
Greater incentives introduced for larger companies
Sanofi's Lantus successor on track
Positive late-stage data for U300 insulin in type 2 diabetes patients
Forest Labs slashes staff and bolsters product portfolio
New CEO Brenton Saunders makes his mark with restructure plans
Biogen Idec's haemophilia candidate faces US delay
FDA extends review of Alprolix
Takeda appoints GSK's Weber as chief operating officer
Could take on CEO role next year
FDA backs new formulation of Noxafil
Merck wins US approval for delayed-release version of anti-infective
Survey to gauge impact of doctor-patient talks in diabetes
Lilly and Boehringer sponsor worldwide study
Smart Glasses: A new look for healthcare?
Wearable computer devices like Google Glass are tipped to become the next big technology trend, and have exciting health applications
-
Counting what countsMeasurement is the lifeblood of communications and brand investment in analytics is poised for steep growth
-
Pharma should not ignore IndiaIt’s complicated, but multinational pharma cannot ignore a market with one billion plus people
-
Sanofi wins two at PMEA 2013Awards haul also includes four high commendations
-
Dementia map reveals extent of under-diagnosisLess than half of patients in England are diagnosed
-
Novartis sets sights on eliminating leprosyThrows weight behind meeting WHO's 2020 eradication goal
-
CHMP backs shorter Cervarix scheduleRevised dosing could make running immunisation programmes with GSK's vaccine easier
-
Ogilvy consolidates Asia Pacific offeringComms firm launches Ogilvy CommonHealth Asia Pacific
-
Adherence programme helps Janssen to PMEA successCompany picks up three awards including Company of the Year
-
Revlimid performance leads Celgene to trio of PMEAsWins Small Company of the Year thanks to work on rare cancer drug
Latest appointments
-
Senior appointment for FleishmanHillardJerry Tolk joins the Atlanta office as senior vice president
-
Lundbeck names SVP for business development and HRJacob Tolstrup is promoted at Danish pharma company
-
Naish leaves Novo Nordisk for MHPHealth consultancy adds several hires
-
Kleemann joins Merck from Boehringer
Appointed head of group tax
-
Senior hire for Just::Health Catherine Barnett becomes third member of the senior management team
Featured jobs
- Senior Brand Manager - Top 20 Pharma
- Negotiable
- CRA II & Senior CRA's - Office or Home-based
- 40,000 to 52,000 per annum
- Account Director - PR, South West London
- Extremely competitive
- Digital Project Managers
- Competitive
Subscribe to our email news alerts
PMHub
Gem Marketing Ltd
GEM, a small but perfectly formed integrated marketing agency servicing the pharmaceutical industry....
Latest intelligence
- Survey: Digital Futures 2014
- Can you help us predict pharma's digital future?...
- Adherence to treatment and side effect management in breast cancer
- The success of treatment for breast cancer is dependent on a high level of adherence, however it is surprisingly common for women with breast cancer to miss doses or stop...
- ASEAN: Domestic vaccines manufacturers
- Selling vaccines in the region places commercial considerations alongside humanitarian obligations...
Quick links
